Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	100.69	374.92	186.82
Graham Fair Price	-25.26	8.26	11.06
PEG	-3.78	-3.90	-3.76
Price/Book	27.88	16.57	12.96
Price/Cash Flow	-18.25	310.07	-379.27
Prices/Earnings	147.61	183.24	74.00
Price/Sales	12.87	33.16	29.38
Price/FCF	-18.25	310.07	-379.27
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	1.92	0.68	0.66
Operating Margin	-49.21	0.06	0.12
ROA	-46.98	0.01	0.02
ROE	0.04	0.02	-48.36
ROIC	0.03	0.03	-14.02
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	< 0.005	2.79	-99.64
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.21	-0.40	-91.69
EPS QOQ	-0.20	-0.47	-138.61
FCF QOQ	-1.78	2.64	48.51
Revenue QOQ	0.26	0.19	-27.97
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	202.43	166.25	-17.87
Days Sales Outstanding (DSO)	40.21	34.69	-13.72
Inventory Turnover	0.44	0.54	21.76
Debt/Capitalization	0.31	0.30	-3.77
Quick Ratio	0.65	0.78	19.83
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	11.14	11.59	4.00
Cash	1.36	1.95	43.39
Capex	-0.08	-0.05	41.15
Free Cash Flow	-0.38	0.62	62.68
Revenue	4.91	5.79	17.83
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.50	1.59	6.22
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	4.99	6.32	26.50
Naive Interpretation	Member

06 - Financial Health · Weak

Rating